Journey Medical Corporation DERM Business Segments — Amortization Impairment And Loss Recovery
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept derm:AmortizationImpairmentAndLossRecovery.
The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Journey Medical Corporation's business segments — amortization impairment and loss recovery.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Journey Medical Corporation's business segments — amortization impairment and loss recovery?
- Journey Medical Corporation (DERM) reported business segments — amortization impairment and loss recovery of $1.86M in Q1 2026.
- How has Journey Medical Corporation's business segments — amortization impairment and loss recovery changed year-over-year?
- Journey Medical Corporation's business segments — amortization impairment and loss recovery increased by 2.8% year-over-year, from $1.81M to $1.86M.
- What does business segments — amortization impairment and loss recovery mean?
- This metric represents non-cash charges related to the write-down of intangible assets or goodwill, as well as potential recoveries from previous impairment losses within the dermatological segment. It reflects the accounting impact of changes in the valuation of the segment's intellectual property, product rights, or acquired assets. Significant fluctuations in this figure can indicate shifts in the long-term economic viability or strategic value of the segment's product portfolio.